medication costs Archives - Ashvinmedicara

Understanding Medication Costs: A Comparison of Branded, U.S. Generics, and Indian Generics

Brian RogersJune 2, 20240214 views

Understanding the distinctions between branded medications, U.S. generics, and WHO-certified generics from India is crucial for consumers aiming to manage healthcare expenses effectively. This article explores the different cost structures associated with each and the significant savings potential offered by Indian generics. It highlights that while branded medications are the most expensive due to research and development costs, U.S. generics provide a more affordable alternative. However, WHO-certified Indian generics offer even greater savings without compromising on quality, thanks to efficient manufacturing and international certification. The piece underscores the importance of verifying the authenticity of online pharmacies and understanding legal and safety considerations to make informed decisions.

Brand-Name vs. Generic Drugs: Are Indian Generics Just as Effective?

Brian RogersJune 2, 20240154 views

The pharmaceutical industry offers a wide range of medications, including high-cost brand-name drugs and more affordable generics. This report analyzes the equivalency in efficacy between Indian WHO-certified generic drugs and their branded counterparts, highlighting differences in inactive ingredients and the economic impact on healthcare. Despite misconceptions, generics contain the same active ingredients and adhere to international quality standards, offering a cost-effective alternative without compromising safety. The lower cost of Indian generics makes essential medications more accessible, particularly in low- and middle-income countries, driving down healthcare costs and expanding access to necessary treatments.

Transparency vs. Secrecy: Ashvin Medicara and LegitScript in the Spotlight

Brian RogersMarch 10, 20240336 views

Ordering medications online from international sources has become popular for those seeking affordable pharmaceuticals, but it comes with challenges, notably the risk of customs seizures. This article explores common reasons for package seizures, such as exceeding allowable quantities and including controlled substances, and provides guidance on mitigating these risks. Understanding and navigating these complexities can help individuals manage their healthcare needs legally and safely, ensuring access to necessary medications.